Navigation Links
Tengion to Host Conference Call to Provide a Business Update and Report Fourth Quarter and Full Year 2012 Financial Results on March 18, 2013
Date:3/11/2013

WINSTON-SALEM, N.C., March 11, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Monday, March 18, 2013, at 9:00 a.m. EDT to provide a business update and discuss its fourth quarter and full year 2012 financial results. 

To participate in the call, please dial 1-866-543-6403 (domestic) or 1-617-213-8896 (international) and reference access code 98136968. The conference call can be accessed from the Investors & News section of the Company's website or directly at http://www.media-server.com/m/p/pfbbcfmc.

A replay of the call will be available one hour after the end of the conference on March 18, 2013 until 11:59 p.m. EDT on March 25, 2013. To access the replay, please dial 1-888-286-8010 (domestic) or 1-617-801-6888 (international) and reference the access code 69683056. The archived webcast will be available for 30 days on the Company's website at www.tengion.com.

About Tengion
Tengion, a clinical-stage regenerative medicine company, is focused on developing its Organ Regeneration Platform™ to harness the intrinsic regenerative pathways of the body to regenerate a range of native-like organs and tissues with the goal of delaying or eliminating the need for chronic disease therapies, organ transplantation, and the administration of anti-rejection medications. An initial clinical trial is ongoing for the Company's most advanced product candidate, the Neo-Urinary Conduit™, an autologous implant that is intended to catalyze regeneration of native-like urinary tissue for bladder cancer patients requiring a urinary diversion following bladder removal. The Company's lead preclinical candidate is the Neo-Kidney Augment™, which is designed to prevent or delay dialysis kidney transplantation by increasing renal function in patients with advanced chronic kidney disease. Tengion has worldwide rights to its product candidates.

 

 

 


'/>"/>
SOURCE Tengion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Tengion Provides Business Update and Reports Third Quarter 2012 Financial Results
2. Tengion to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
3. Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina
4. Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting
5. ISPE Conference to Benchmark and Advance Quality by Design in the Biopharmaceutical Industry
6. Discovery Labs to Report Fourth Quarter 2012 Results and Hold Conference Call on Wednesday, March 13, 2013
7. Registration Now Open for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego
8. Fourth Annual Bay Area Biomedical Device Conference: March 27th, 2013 at San Jose State University
9. Palatin Technologies, Inc. To Present At The Cowen & Company 33rd Annual Health Care Conference
10. AVANIR Pharmaceuticals To participate in two conferences in March
11. Lexicon To Present At The Cowen Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... December 7, 2016 Regen BioPharma Inc. ... Journal of Molecular Sciences a team of scientists in ... have demonstrated that expression of NR2F6 in patients with ... for NR2F6 in patient,s cervical cancer tissue as well as ... "This is an interesting study and the first that ...
(Date:12/7/2016)... ... December 07, 2016 , ... Proscia ... a new service to enable rapid migration of large pathology data sets to ... of the factors limiting adoption of digital pathology. Proscia’s free massive dataset migrator ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... an early access program for SmartBiome -- a novel metagenomic deep-sequencing research ... specific enrichment and detection of hundreds of different genes. The selective early ...
(Date:12/6/2016)... Texas , Dec. 6, 2016 The ... for its adoption of arnica ( Arnica montana ... support to ABC,s HerbMedPro database, a ... important scientific and clinical research data on the ... popular herbs. Naturopathica, a wellness company ...
Breaking Biology Technology:
(Date:11/14/2016)...  xG Technology, Inc. ("xG" or the "Company") (Nasdaq: ... for use in challenging operating environments, announced its results ... will hold a conference call to discuss these results ... (details below). Key Recent Accomplishments ... agreement to acquire Vislink Communication Systems. The purchase is ...
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
(Date:6/21/2016)... Columbia , June 21, 2016 ... to the new role of principal product architect ... named the director of customer development. Both will ... chief technical officer. The moves reflect NuData,s strategic ... in response to high customer demand and customer ...
Breaking Biology News(10 mins):